Skip to content Skip to navigation

Intravitreal bevacizumab for peripapillary choroidal neovascular membranes.

TitleIntravitreal bevacizumab for peripapillary choroidal neovascular membranes.
Publication TypeJournal Article
Year of Publication2012
AuthorsDavis, Andrew S., Folk James C., Russell Stephen R., Sohn Elliott H., Sohn Elliot H., H Boldt Culver, Stone Edwin M., and Mahajan Vinit B.
JournalArch Ophthalmol
Date Published2012 Aug
KeywordsAdult, Aged, Aged, 80 and over, Angiogenesis Inhibitors, Antibodies, Monoclonal, Humanized, Bevacizumab, Choroidal Neovascularization, Female, Fluorescein Angiography, Humans, Intravitreal Injections, Macular Degeneration, Male, Middle Aged, Retreatment, Subretinal Fluid, Tomography, Optical Coherence, Treatment Outcome, Vascular Endothelial Growth Factor A, Visual Acuity
Alternate JournalArch. Ophthalmol.
PubMed ID22893085